GSK Lifts Outlook Again After Strong Sales of New RSV Shot
GSK Plc raised its guidance for the second time this year as demand surges for its breakthrough vaccine
2023-11-01 16:22
‘Expensive’ Franc Beats Peers as JPMorgan Sees Further Gains
The Swiss franc is back on track to be the strongest performing G-10 currency against the dollar this
2023-11-01 15:56
Saudi Arabia’s Tabby Valued at $1.5 Billion in Pre-IPO Fundraise
Saudi Arabia-based Tabby raised $200 million in a funding round that values the buy-now-pay-later firm at over $1.5
2023-11-01 14:48
In Major Protectionist Move, Spain Considers Stake in Telefonica
Spain is considering whether to shield its “most strategic” company from foreign takeovers in what could be the
2023-11-01 13:46
Asia Factories Grapple With High Costs Amid Israel-Hamas War
Manufacturing activity in Asia slumped again in October as conflict in the Middle East drove oil prices higher,
2023-11-01 11:27
South Korean Exports Return to Growth in Boost to Outlook
South Korea’s exports rose for the first time since late last year in a positive sign for the
2023-11-01 10:49
Oil Edges Higher With Focus on Israel-Hamas War, Shaky Demand
Oil advanced after slumping in the first two days of the week, as a still-contained Israel-Hamas war caused
2023-11-01 10:29
South Korea Oct exports rise for first time in 13 months
SEOUL South Korea's exports in October rose in annual terms for the first time in 13 months, trade
2023-11-01 08:58
Chesapeake Energy tops profit estimates as costs ease
By Sourasis Bose (Reuters) -Chesapeake Energy beat Wall Street estimates for third-quarter profit on Tuesday, as lower overall costs helped
2023-11-01 07:29
Cornell Antisemitic Violence Threats Lead Police to Suspect
New York State Police are questioning a suspect about online threats of mass shooting and antisemitic violence at
2023-11-01 07:17
US and Israel Weigh Peacekeepers for the Gaza Strip After Hamas
The US and Israel are exploring options for the future of the Gaza Strip, including the possibility of
2023-11-01 05:52
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 05:25